Form 4: Astera Labs CEO Sells Over 126,000 Shares Under Pre-Arranged Trading Plan

Astera Labs, Inc. CEO Jitendra Mohan sold a total of 126,258 shares of common stock on July 17 and July 18, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Summary

• Jitendra Mohan, Chief Executive Officer and Director of Astera Labs, Inc. (ALAB), reported sales of common stock.
• On July 17, 2025, a total of 80,503 shares were sold at a weighted average price of $94.3653 per share.
• On July 18, 2025, an additional 45,755 shares were sold at a weighted average price of $100.2542 per share.
• The sales were executed automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Mohan on December 2, 2024.
• Following these transactions, Mr. Mohan's beneficial ownership includes 2,262,318 shares held directly and 7,500,778 shares held indirectly through various trusts, totaling 9,763,096 shares.
• The indirect holdings are distributed among a Living Trust (4,318,133 shares), an estate planning Trust (738,123 shares), 2021 Trust 1 (738,130 shares), 2021 Trust 2 (738,130 shares), 2022 Trust 1 (488,131 shares), and 2022 Trust 2 (488,131 shares).

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can be perceived negatively, the fact that it was conducted under a pre-arranged Rule 10b5-1 plan mitigates concerns about opportunistic selling based on non-public information. It's a routine financial planning event for an executive.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which indicates the transactions were scheduled in advance and not based on immediate, non-public information.

Negatives

• The Chief Executive Officer and Director sold a significant number of shares, which can sometimes be perceived negatively by investors as it reduces insider alignment with shareholder interests.

Risks

• Potential negative market perception due to insider selling, even if pre-planned, which could put downward pressure on the stock price.

Future Outlook

NA

Industry Context

This Form 4 filing reports routine insider stock sales by a key executive, which is a common occurrence in publicly traded companies. It does not provide information on broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders may observe a reduction in the CEO's direct and indirect holdings, which could lead to questions about management's long-term alignment, though the 10b5-1 plan mitigates immediate concerns.

Key Dates

Keywords

Astera Labs, ALAB, Jitendra Mohan, SEC Form 4, Insider Trading, Stock Sale, Rule 10b5-1 Plan, Common Stock, Beneficial Ownership, CEO, Director